Recombinant Human CCL25 Protein，His

CCL25, also known as thymus-expressed chemokine (TECK), is a human chemokine that plays a crucial role in the migration and localization of T lymphocytes, particularly in the mucosal immune response. It is predominantly expressed in the thymus and intestinal tissues, where it facilitates the homing of naive T cells to gut-associated lymphoid tissues (GALT). The study of CCL25 has garnered significant interest due to its potential applications in understanding autoimmune diseases, inflammatory bowel disease, and various cancers, as it is involved in the recruitment of immune cells to sites of inflammation. Recent advancements in recombinant protein technology have enabled the production of CCL25 in large quantities, allowing researchers to investigate its structural and functional properties. This recombinant protein serves as a valuable tool in elucidating the signaling pathways and biological mechanisms underlying T cell trafficking. Moreover, CCL25's role as a therapeutic target is being explored, with the potential to develop novel treatments that modulate immune responses in various pathological conditions. Understanding CCL25's interactions with its receptors and its downstream signaling pathways could pave the way for innovative therapeutic approaches in immunology and oncology. As such, research on CCL25 recombinant proteins continues to be a significant area of interest, offering insights into the complexities of immune system regulation and potential intervention strategies for immune-mediated diseases.